DA RPB190904 memo-main
Ended Awarded Last action
- Contract number
- 75P00220F80004
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Office of the Assistant Secretary for Administration
Department of Health and Human Services
- Obligated
- $166,621
Award facts
- Contract value 100% obligated
- $166,621.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$115,869 | |
| Original award | $282,490 |
About this award
GlaxoSmithKline, LLC was awarded a $166,621.45 delivery order (V797P-2298D/75P00220F80004) by the Office of the Assistant Secretary for Administration on December 2, 2019, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract utilizes firm fixed pricing with an ultimate completion date of January 1, 2026, and carries no set-aside designation. The work will be performed in Research Triangle Park, North Carolina. This delivery order represents a continuation of GlaxoSmithKline's substantial role as a pharmaceutical supplier to federal agencies, leveraging the company's broader Federal Supply Schedule contract with a $3.9 billion ceiling.
GlaxoSmithKline's federal contracting portfolio demonstrates its critical involvement in national healthcare and immunization programs across multiple agencies including the Centers for Disease Control and Prevention, Department of Veterans Affairs, and Department of Health and Human Services. The company maintains numerous indefinite delivery contracts for vaccines and pharmaceutical products, with individual contract values ranging from $13.9 million to $182.6 million. This delivery order award reflects the company's established capability in supplying pharmaceutical products and medical countermeasures to support government healthcare objectives and emergency preparedness initiatives.
Quick answers
Who was awarded contract 75P00220F80004?
75P00220F80004 was awarded to Glaxosmithkline, LLC by Office of the Assistant Secretary for Administration (Department of Health and Human Services) on December 2, 2019.
How much is contract 75P00220F80004 worth?
The government has obligated $166,621 on 75P00220F80004.
Is contract 75P00220F80004 an order under another contract?
Yes. 75P00220F80004 is a delivery order under V797P2298D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 75P00220F80004 competed?
The extent of competition for 75P00220F80004 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award